An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.

Back

ESC Professional Premium Access

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.

Session: Innovations in public health and health economics (1)

Topic: Health Economics

Speaker: Professor A. Goette (Paderborn, DE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)

40 presentations

0 follower

4 more presentations in this session

Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography

Speaker: Doctor J. Chung (Goyang, KR)

Quantity and quality of shared decision making incorporation across major international cardiology guidelines

Speaker: Doctor B. MacDonald (Vancouver, CA)

Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries

Speaker: Doctor M. Walli-Attaei (Oxford, GB)

Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study

Speaker: Mr A. Holt (Copenhagen, DK) Miss J. Liang (Auckland, NZ)

Access the full session

Innovations in public health and health economics (1)

Speakers: Professor A. Goette, Doctor J. Chung, Doctor B. MacDonald, Doctor M. Walli-Attaei, Mr A. Holt...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.

About the speaker

Professor Andreas Goette

4 more presentations in this session

Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography

Quantity and quality of shared decision making incorporation across major international cardiology guidelines

Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries

Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study

Access the full session

Innovations in public health and health economics (1)

About the event

ESC Congress 2023

ESC 365 is supported by